{"organizations": [], "uuid": "2a7cfed8b5f73183d4568f40fa4a3bf3061aea7b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/11/business-wire-eos-imaging-reports-1st-quarter-2018-revenue-growth-of-34-percent-and-full-year-2017-results.html", "country": "US", "domain_rank": 767, "title": "EOS imaging Reports 1st Quarter 2018 Revenue Growth of 34% and Full Year 2017 Results", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.49, "site_type": "news", "published": "2018-04-11T20:26:00.000+03:00", "replies_count": 0, "uuid": "2a7cfed8b5f73183d4568f40fa4a3bf3061aea7b"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/11/business-wire-eos-imaging-reports-1st-quarter-2018-revenue-growth-of-34-percent-and-full-year-2017-results.html", "ord_in_thread": 0, "title": "EOS imaging Reports 1st Quarter 2018 Revenue Growth of 34% and Full Year 2017 Results", "locations": [], "entities": {"persons": [{"name": "marie meynadier", "sentiment": "none"}], "locations": [{"name": "paris", "sentiment": "none"}, {"name": "paris", "sentiment": "none"}, {"name": "north america", "sentiment": "none"}], "organizations": [{"name": "euronext", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "PARIS--(BUSINESS WIRE)--\nRegulatory News:\nEOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI), the pioneer of orthopedic medical imaging 2D / 3D, today announces its first quarter 2018 consolidated sales revenue and consolidated results for the full year ended December 31, 2017, as adopted by the Board of Directors on April 11, 2018.\nFIRST QUARTER 2018 & FULL YEAR 2017 HIGHLIGHTS\nQ1 2018 sales increased 34% to €9.5 million, driven by 54% growth in the North American region\n(76% exluding forex impact) coupled with an increase in average selling price (ASP) despite an unfavorable forex effect 2017 revenue up 21% to €37.1 million taking the 5-year CAGR to 32% (2012-2017) Gross margin temporarily impacted during the reorganization in North America during 2017 Robust control of operating expenses Cash position of €6.9 million as of December 31, 2017, strengthened in January 2018 by drawing a fourth tranche of €4.9 million on the bond issue\nMarie Meynadier, CEO of EOS imaging, commented: \"2017 was a year rich in corporate achievements for EOS imaging. We successfully completed an in-depth remodeling of our North American operations in record time to support our development in this key market, while maintaining strong growth of 54% on the combination of the EMEA and APAC markets. The strong momentum in North America evidenced by Q1 2018 sales growth supports our confidence about the effectiveness of this new organization.\nSales growth, driven by the contribution of the North American zone and significant improvement in selling prices, will contribute positively to the increase in the gross margin in 2018. This combined with continued cost control of operating expenses will allow to significantly reduce operating losses over the coming year.\nThe company is further strengthened and well-positioned to respond effectively to the strong acceleration of the adoption of the EOS® system and continue to provide healthcare professionals and patients with innovative solutions tailored to their needs.”\nREVENUE UP 34% IN FIRST QUARTER 2018, DRIVEN BY NORTH AMERICA\n€ millions Q1 2018 Q1 2017 Var Equipment sales 7.56 5.47 38% As a % of total revenues 79% 77% Sales of maintenance 1.73 1.40 24% As a % of total revenues 18% 19% Sales of consumables and services 0.26 0.26 0% As a % of total revenues 3% 4% Total revenues 9.54 7.13 34% NB. Unaudited data Equipment sales increased 38% compared to the first quarter of 2017 to €7.56 million , following the sales of 19 EOS® systems, compared to the 14 systems sold in first quarter 2017. Average selling price reached €398 thousand, including currency effects, compared with €391 thousand in 2017.\nSales of maintenance contracts increased 24% to €1.7 million. This reflects the continued increase in the installed base of EOS® systems and an associated high contract subscription rate after warranty.\nSales of consumables and services were stable at €0.3 million .\n€ millions Q1 2018 Q1 2017 Var EMEA 3.53 3.21 10% North America 3.81 2.48 54% Asia-Pacific 2.21 1.44 53% Total revenues 9.54 7.13 34% NB. Unaudited data Sales in the North American market grew at a historic level of 54% to €3.8 million (76% growth at constant exchange rate). The strong dynamics observed in the first quarter in the region confirms the trend observed in the fourth quarter of 2017 and abodes for solid growth in coming quarters. ASP in USD in North America was 10% above that of the first quarter of 2017.\nSales rose 54% in the Asia-Pacific region to €2.2 million , boosted by a strong Australian market and new milestones in China.\nIn the EMEA region, the company observed continued momentum on all key markets , with sales growth of 10% at €3.5 million.\nA FULL YEAR OF STRONG ACHIEVEMENTS IN 2017\nRevenue growth of 21% to €37.1 million\nEOS imaging reported full year 2017 revenue of €37.1 million, an increase of 21% compared to the prior year.\nEquipment sales grew by 20% to €30.0 million. Recurring revenues were €7.1 million, up 24% compared to 2016. Recurring revenues included sales of maintenance of €5.9 million and sales of consumables and services of €1.2 million.\nIn addition, EOS imaging received €1.7 million in public grants in 2017 to support ongoing innovation, including a research tax credit recognized in “Other income”.\nGross margin temporarily impacted at 45.3%\nGross margin for the full year 2017 was 45.3%, a decrease compared to the prior year mainly due to a reduction in average selling price which was partially compensated by reductions in average cost of sales.\nAverage selling price was impacted by (1) the remodeling of the US organization, leading to a lower North American contribution to global revenue as well as a decrease in ASP in the first half of the year, and (2) a forex effect.\nSolid control of operating expenses\nOperating expenses excluding cost of share-based payments for the full year 2017 totaled €23.4 million, up 11% compared to the prior year. Global operating expenses were 24.3 million and included a €0.4 million increase in the cost of share-based payments.\nOperating loss for the full year 2017 was €5.8 million compared with an operating loss of €4.6 million in 2016.\nNet financial expense for the full year 2017 totaled €2.0 million, compared to €1.6 million in 2016, reflecting interest expense on the Company’s €15.0 million debt financing\nNet loss for the full year 2016 was €7.8 million compared with a net loss of €6.2 million in the previous year.\nSummarized Income statement\nIn millions of euros 2017 2016 Revenue 37.09 30.77 Other income 1.72 2.33 Total income 38.81 33.10 Direct cost of sales (20.29) (16.20) Gross margin 16.81 14.58 as a % of revenue 45.3% 47.4% Indirect cost of production and services (4.12) (3.83) Research & development (4.10) (3.89) Sales & marketing (9.81) (8.66) Regulatory expenses (0.74) (0.70) Administrative costs (4.61) (3.91) Total operating expenses excluding cost of goods and share-based payments (23.38) (20.99) Share-based payments (0.91) (0.48) Total operating expenses (24.29) (21.46) Operating income/(loss) (5.77) (4.56) Net financial income/(expense) (2.01) (1.61) Net income/(loss) (7.78) (6.17) NB. Unaudited data Net cash at December 31, 2017: €6.9 million\nAs of December 31, 2017, EOS imaging’s net cash totaled €6.9 million, compared with €14.9 million at December 31, 2016. A fraction of the first tranche of the IPF debt was reimbursed in 2017, and a rescheduling and drafting of a €4.9 million fourth tranche concluded in early 2018.\nConsolidated equity stood at €23.2 million at December 31, 2017, compared with €22.8 million at December 31, 2016.\nABOUT EOS imaging\nEOS imaging designs, develops and markets EOS®, a major innovative medical imaging solution dedicated to osteoarticular pathologies and orthopaedics combining equipment and services targeting a $2M per year market opportunity. EOS imaging is currently present in 27 countries, including the United States under FDA agreement, Japan, China and the European Union under CE labelling, through approximately 250 EOS® installed representing around one million patient exams every year. Revenues were €37.1M in 2017, e.g. a +32% CAGR over 2012-2017.\nFor more information, please visit www.eos-imaging.com .\nEOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.\nEOS imaging is listed on Compartment C of Euronext Paris\nISIN: FR0011191766 – Ticker: EOSI\nNext press release: Release of Q2 2018 sales in July 17, 2018\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180411006076/en/\nEOS imaging\nMarie Meynadier, CEO, +33 1 55256060\ninvestors@eos-imaging.com\nor\nPress Relations (US)\nThe Ruth Group\nJoanna Zimmerman, +1 646-536-7006\njzimmerman@theruthgroup.com\nor\nInvestor Relations (US)\nThe Ruth Group\nMatt Picciano / Emma Poalillo\nPh: +1 646-536-7008 / 7024\neos-imaging@theruthgroup.com\nSource: EOS imaging", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.eos-imaging.com&esheet=51787196&newsitemid=20180411006076&lan=en-US&anchor=www.eos-imaging.com&index=1&md5=3166c080651f955148fdd055f87c67ef", "https://www.businesswire.com/news/home/20180411006076/en/"], "published": "2018-04-11T20:26:00.000+03:00", "crawled": "2018-04-11T22:17:14.023+03:00", "highlightTitle": ""}